Novo Nordisk (Ondo Tokenized Stock) (NVOON): issuer, networks, and where it trades

NVOON is a tokenized stock issued by Ondo Global Markets (BVI) Limited, representing a structured note that provides holders with synthetic exposure to Novo Nordisk (NVO). This instrument is designed as a debt instrument with redemption rights and a first-priority security interest in the collateral, rather than direct ownership of the underlying shares. Consequently, holders of NVOON do not possess traditional shareholder rights such as voting or dividend entitlements associated with owning NVO directly. The instrument is distributed under Regulation S, meaning it is available only to non-U.S. persons and is subject to KYC and wallet screening. The specific blockchain network(s) on which NVOON exists is not detailed in the legal substance. It remains unclear how dividends and stock splits of the underlying asset are managed in relation to this structured note.

NVOON data covers 1 venues. The available products determine which staking rates, withdrawal fees and funding rates appear. Sources include exchange APIs, protocols and aggregators. Scheduled collection: exchange staking every 10 minutes, funding every 10 minutes, fees and network availability every 30 minutes. On-chain yields follow their source schedule.